Yesterday, P4AD, in collaboration with We Are Más, and Brown University’s Information Futures Lab released The Price Patients Pay: How Unaffordable Prescription Drugs Shape the Health, Finances, and…
News Aug 28, 2026Big Pharma suffered two more courtroom defeats this week, delivering the 24th and 25th legal victories for Medicare negotiation and the patients who fought to make it law.
News Aug 21, 2026In honor of National Patient Advocacy Day on Wednesday, P4AD released a new video, Your Voice Is Your Power, following patient advocates Kris Garcia, Sarah Wisniewski, and Amelia Schachter as they…
News Aug 14, 2026Six months after the TrumpRx platform launched, we’re getting a clearer picture of who the program is helping — and its limitations.
News Aug 7, 2026An unnoticed CMS policy change delayed Medicare price negotiation for AbbVie’s blockbuster drug Creon for an additional seven years — despite Creon, a pancreatic enzyme replacement therapy…
News Jul 31, 2026CMS announced that Xeljanz and Xeljanz XR will be removed from the Medicare Drug Price Negotiation Program in 2029 after determining the drugs will soon face generic competition.
News Jul 24, 2026With two markups this week, the House E&C and Senate HELP Committees advanced three bipartisan, P4ADNow-supported drug pricing reforms.
Press Releases Jul 22, 2026Today, the Senate Health, Education, Labor and Pensions (HELP) Committee advanced the INSULIN Act (S. 4189), a bipartisan bill which is supported by P4ADNow.
Press Releases Jul 21, 2026Today, the House Energy and Commerce Committee advanced two bipartisan bills supported by P4ADNow that would increase competition and help lower prescription drug costs:
News Jul 17, 2026The Senate Judiciary Committee and the House Energy and Commerce Committee each held hearings this week on drug development and access, with lawmakers from both parties highlighting industry…
1:49 · Watch on YouTube
3:50 · Watch on YouTube
0:51 · Watch on YouTube
